Table 1 Sample characteristics
Sample | Clinical status | PVL (%) | DFA machine | Final state | Integration sites |
|---|---|---|---|---|---|
F1 | AC | 7.57 | M1 | q1 | 876 |
F2 | AC | 5.24 | M1 | q1 | 802 |
F3 | AC | 7.16 | M1 | q1 | 1473 |
F4 | SM | 6.02 | M1 | q1 | 1827 |
F5 | SM | 31.15 | M4 | q2 | 225 |
F6 | SM | 23.56 | M2 | q2 | 398 |
F7 | SM | 36.63 | M4 | q2 | 570 |
F8 | SM | 43.24 | M7 | q3 | 417 |
F9 | Chronic | 28.53 | M4 | q2 | 260 |
F10 | Chronic | 15.25 | M4 | q2 | 1345 |
F11 | Chronic | 100.70 | M3 | q3 | 73 |
F12 | Chronic | 83.81 | M3 | q3 | 65 |
F13 | Acute | 64.43 | M6 | q3 | 138 |
F14 | Acute | 27.92 | M5 | q3 | 390 |
F15 | Acute | 51.90 | M3 | q3 | 40 |
F16 | Acute | 51.42 | M3 | q3 | 19 |
F17 | AC | 1.24 | ND | ND | 233 |
F18 | AC | 3.52 | ND | ND | 739 |